GlassScriptPhysician profile
Renee Peterkin-Mccalman
NPI 1083097349
$15,533.81
in general payments reported to CMS, 2019-2025
37 companies · $3,536 in 2025
The $3,536 reported for 2025 was more than what 80% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $590 · 2021: $2,245 · 2022: $2,396 · 2023: $3,180 · 2024: $3,312 · 2025: $3,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $19.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,009.13 |
| Education | $19.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,217.14 | 2019-2025 | |
| Amgen INC. | $1,730.80 | 2020-2025 | Krystexxa, Otezla, Tavneos |
| Ucb, INC. | $1,604.20 | 2020-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $1,288.80 | 2020-2025 | Tremfya, Simponi, Simponi Aria |
| Pfizer INC. | $979.89 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $954.62 | 2019-2025 | |
| Glaxosmithkline, LLC. | $667.31 | 2020-2025 | Benlysta, Nucala |
| Astrazeneca Pharmaceuticals LP | $603.65 | 2021-2025 | Saphnelo |
| E.R. Squibb & Sons, L.L.C. | $242.77 | 2020-2023 | Orencia |
| Fresenius Kabi USA, LLC | $200.08 | 2023-2025 | Tyenne, Idacio |
| Lilly USA, LLC | $199.85 | 2020-2025 | Taltz |
| Mallinckrodt Hospital Products INC. | $193.59 | 2023-2025 | Acthar |
| Organon LLC | $175.67 | 2023-2025 | Renflexis, Hadlima |
| Radius Health, INC. | $162.55 | 2020-2025 | Tymlos |
| Sobi, INC | $148.32 | 2020-2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Peterkin-Mccalman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.